Monday, December 22, 2025 | 03:30 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch
Home / India News / Suven Life Sciences secures four product patents for their NCE's

Suven Life Sciences secures four product patents for their NCE's

Image

Capital Market
Last Updated : May 24 2016 | 12:06 AM IST

In Australia, Eurasia, Israel and USA

Suven Life Sciences announced that they secured patents in Australia, Eurasia, Israel and USA to their New Chemical Entities for CNS therapy through mechanism of action - H3 Inverse agonist and these patents are valid until 2032, 2030, 2031 and 2032 respectively.

Powered by Capital Market - Live News

 

More From This Section

Board of Radhe Developers (India) approves change in directorate

Board of Radhe Developers (India) approves change in directorate

Outcome of board meeting of Emkay Global Financial Services

Outcome of board meeting of Emkay Global Financial Services

Outcome of board meeting of HSIL

Outcome of board meeting of HSIL

Board of Radhey Trade Holding approves proposal to delist shares from Calcutta Stock Exchange

Board of Radhey Trade Holding approves proposal to delist shares from Calcutta Stock Exchange

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 23 2016 | 12:11 PM IST

Explore News

India vs Pakistan U19 Asia Cup Final LIVEStocks to Watch TodayICICI Prudential AMC IPO Listing LIVEIdea Vodofone ShareAeroflex Industries ShareOTT Releases This WeekChristmas Gift IdeasUS Visa BulletinCAT Result 2025Personal Finance
Business Standard
HOT STOCKS
TOP SECTIONS
KEY EVENTS
Copyrights © 2025 Business Standard Private Ltd. All rights reserved
LinkedIN Icon